A new plasmid carrying mphA causes prevalence of azithromycin resistance in enterotoxigenic Escherichia coli serogroup O6
- PMID: 32782021
- PMCID: PMC7418381
- DOI: 10.1186/s12866-020-01927-z
A new plasmid carrying mphA causes prevalence of azithromycin resistance in enterotoxigenic Escherichia coli serogroup O6
Abstract
Background: At present, azithromycin has become an effective treatment for severe diarrhea caused by Enterotoxigenic Escherichia coli (ETEC) infection. However, enterobacteria have begun to develop resistance to azithromycin and have attracted attention in recent years. This study conducted to described the emergence of a high proportion of azithromycin-resistant ETEC serogroup O6 strains in Shanghai and to analyzed the mechanisms of azithromycin resistance.
Results: Strains from adult diarrhea patients with ETEC serogroup O6 infections were collected by Shanghai Diarrhea Surveillance Network and the Foodborne Surveillance Network from 2016 to 2018. We tested 30 isolates of ETEC O6 serogroup, 26 of which were resistant to azithromycin. Phylogenetic analysis revealed that these ETEC serogroup O6 strains have formed an independent dominant clone. S1-PFGE and southern blotting revealed the presence of the mphA gene on the 103 kb plasmid. Illumina and Nanopore sequencing and plasmid coverage analysis further confirmed that azithromycin-resistant strains carried a novel IncFII plasmid harboring mphA and blaTEM-1 resistance genes.
Conclusions: This is the first study to report a high proportion of azithromycin resistance in a particular ETEC serogroup due to a specific plasmid carrying mphA. Our findings indicate the rapid spread of azithromycin resistance, highlighting the urgency of stringent surveillance and control measure.
Keywords: Azithromycin; Enterotoxigenic Escherichia coli; Nanopore sequencing; Plasmid; Whole-genome sequencing; mphA.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
[The first identification of epidemic clone of enterotoxic Escherichia coli O∶6 serogroup highly associated with azithromycin resistance in Shanghai].Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Nov 10;40(11):1403-1408. doi: 10.3760/cma.j.issn.0254-6450.2019.11.012. Zhonghua Liu Xing Bing Xue Za Zhi. 2019. PMID: 31838812 Chinese.
-
Genome wide characterization of enterotoxigenic Escherichia coli serogroup O6 isolates from multiple outbreaks and sporadic infections from 1975-2016.PLoS One. 2018 Dec 31;13(12):e0208735. doi: 10.1371/journal.pone.0208735. eCollection 2018. PLoS One. 2018. PMID: 30596673 Free PMC article.
-
Multidrug resistance and multivirulence plasmids in enterotoxigenic and hybrid Shiga toxin-producing/enterotoxigenic Escherichia coli isolated from diarrheic pigs in Switzerland.Vet J. 2019 Feb;244:60-68. doi: 10.1016/j.tvjl.2018.12.015. Epub 2018 Dec 12. Vet J. 2019. PMID: 30825896
-
Recent Antimicrobial Resistance Situation and Mechanisms of Resistance to Key Antimicrobials in Enterotoxigenic Escherichia coli.Biol Pharm Bull. 2025;48(3):222-229. doi: 10.1248/bpb.b24-00649. Biol Pharm Bull. 2025. PMID: 40024692 Review.
-
Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.Appl Microbiol Biotechnol. 2012 Mar;93(6):2291-300. doi: 10.1007/s00253-012-3930-6. Epub 2012 Feb 16. Appl Microbiol Biotechnol. 2012. PMID: 22350259 Review.
Cited by
-
Discerning the role of polymyxin B nonapeptide in restoring the antibacterial activity of azithromycin against antibiotic-resistant Escherichia coli.Front Microbiol. 2022 Sep 21;13:998671. doi: 10.3389/fmicb.2022.998671. eCollection 2022. Front Microbiol. 2022. PMID: 36212888 Free PMC article.
-
Two-Dose Ceftiofur Treatment Increases Cephamycinase Gene Quantities and Fecal Microbiome Diversity in Dairy Cows Diagnosed with Metritis.Microorganisms. 2023 Nov 8;11(11):2728. doi: 10.3390/microorganisms11112728. Microorganisms. 2023. PMID: 38004740 Free PMC article.
-
Minimal Impact on the Resistome of Children in Botswana After Azithromycin Treatment for Acute Severe Diarrheal Disease.J Infect Dis. 2024 Jul 25;230(1):239-249. doi: 10.1093/infdis/jiae049. J Infect Dis. 2024. PMID: 39052715 Free PMC article. Clinical Trial.
-
Bacterial Communities and Resistance and Virulence Genes in Hospital and Community Wastewater: Metagenomic Analysis.Int J Mol Sci. 2025 Feb 26;26(5):2051. doi: 10.3390/ijms26052051. Int J Mol Sci. 2025. PMID: 40076673 Free PMC article.
-
Upregulation of outer membrane porin gene ompC contributed to enhancement of azithromycin susceptibility in multidrug-resistant Escherichia coli.Microbiol Spectr. 2024 Apr 2;12(4):e0391823. doi: 10.1128/spectrum.03918-23. Epub 2024 Mar 5. Microbiol Spectr. 2024. PMID: 38441474 Free PMC article.
References
-
- Madhavan TP, Sakellaris H. Colonization factors of enterotoxigenic Escherichia coli. Adv Appl Microbiol. 2015;90:155–197. - PubMed
-
- von Mentzer A, Connor TR, Wieler LH, Semmler T, Iguchi A, Thomson NR, Rasko DA, Joffre E, Corander J, Pickard D, et al. Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution. Nat Genet. 2014;46(12):1321–1326. - PubMed
-
- Li Y, Luo Q, Shi X, Lin Y, Qiu Y, Lv D, Jiang Y, Chen Q, Jiang M, Ma H, et al. Phenotypic and genotypic characterization of clinical Enterotoxigenic Escherichia coli Isolates from Shenzhen, China. Foodborne Pathog Dis. 2017;14(6):333–340. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 2018YFC1603801/National Key R&D Program of China/International
- 2017YFC1600105/National Key R&D Program of China/International
- 2018ZX10101003/National Major Science and Technology Projects of China/International
- 2018ZX10714002/National Major Science and Technology Projects of China/International
- 81872678/National Nature Science Foundation of China/International
LinkOut - more resources
Full Text Sources
Medical